Z-0751-2024 Class II Ongoing

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-0751-2024 was initiated by Randox Laboratories Ltd. on Nov 13, 2023 and is designated Class II. Reason for recall: There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on… The recall status is ongoing.

Recall details

Product Type
Devices
Report Date
Jan 24, 2024
Initiation Date
Nov 13, 2023
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Calibration Serum Level 3. CAL 3, REF CAL2351. Human Assayed Multi-Sera Level 2 (HN1530) Human Assayed Multi-Sera Level 3 (HE 1532)

Reason for recall

There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on the IFU of Human Assayed Multi-Sera Level 2 (HN1530) for TBIC taget value and on IFU of Human Assayed Multi-Sera Level 3 (HE 1532) for Lipase target value.

Distribution pattern

US Nationwide distribution.

Code information

UDI-DI: 05055273200966, lot1260UE, exp. 28 Nov 2024; lot 1262UE, exp. 28 Jan 2025; and lot 1315UE, exp. 28 May 2025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0751-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0751-2024. Report a data issue: hello@regdatalab.com.